SERA

SERA PROGNOSTICS INC

SERA·81749D107·US·Common Stock·Healthcare - Medical Devices-13D/G

CLASS A COM

SERA (SERA PROGNOSTICS INC) is held by 34 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($11.2M), Aberdeen Group plc ($5.2M), VANGUARD CAPITAL MANAGEMENT LLC ($2.4M). Net institutional sentiment: Bearish.

34
Holders
Avg rating(8 Elite)
$23.5M
Total Value
31% (41)
Fund Consensus
9 buying - 20 selling
SERASmart Money Verdict
View all
Held by 34 funds
8 elite
Who's Trading
InsiderLZLindgardt ZhenyaSell $14KJun 11, 2026
InsiderAAAerts AustinSell $4KJun 11, 2026
InsiderJBJackson BenjaminSell $4KJun 11, 2026
InsiderIDInglis Tiffany Eul DavisSell $727.62Jun 11, 2026
InsiderAJAnderson Dyaarl Lee Jr.Sell $10KJun 11, 2026
InsiderLZLindgardt ZhenyaSell $43KJun 9, 2026
InsiderAAAerts AustinSell $11KJun 9, 2026
ActivistWAWhetstone Capital Advisors, LLC8.6%May 1, 2026
InsiderLZLindgardt ZhenyaSell $6KMar 11, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.0.0%Aug 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.5M$11.2M0.1%-64.61%
0
Increased
2.6M(+11.9%)$5.2M0.0%-45.14%
30
New
1.2M$2.4M0.0%-6.64%
36
Decreased
536,761$1.1M0.0%-28.03%
0
Increased
363,617(+8.7%)$738,5110.0%-58.32%
18
Decreased
248,909(-64.8%)$505,2850.0%-43.32%
0
Increased
196,105(+5.0%)$398,0930.0%-71.52%
17
New
169,661$344,4120.0%-6.64%
33
Unchanged
124,792$253,3280.0%-66.72%
0
Increased
105,017(+29.7%)$213,1840.0%-59.86%
20
Unchanged
96,535$195,9660.0%-70.79%
0
Decreased
91,504(-19.1%)$185,7530.0%-57.05%
0
Decreased
60,927(-19.1%)$123,6820.0%-65.54%
0
Decreased
53,908(-21.7%)$109,4330.0%-32.07%
0
Unchanged
42,234$85,7350.0%-78.30%
0
Decreased
31,967(-12.9%)$64,8930.0%-33.02%
0
Decreased
31,428(-13.5%)$63,7990.0%-57.87%
0
Unchanged
25,000$50,7500.0%-32.07%
0
Unchanged
21,964$44,5870.0%-35.41%
0
Decreased
19,917(-31.3%)$40,4320.0%-49.34%
0

Showing 1-20 of 41

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used